A recent national report found Washington state's biotech venture capital funding faltering in early 2015. But that report doesn't tell the full story. Factoring in the life sciences industry overall, the first quarter of this year fared much better. In Washington state there were about $22.8 million of life science venture capital funding transactions in the first quarter of the year, according to the Washington Biotechnology & Biomedical Association. That's compared to just $500,000 in biotech VC funding recorded in a report by MoneyTree compiled by PricewaterhouseCoopers and the National Venture Capital Association.
